Ginkgo Bioworks Holdings Inc vs Nasdaq100 ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.1 (market cap $590.53M), while Nasdaq100 ETF trades at $721.48. The key difference: Nasdaq100 ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | QQQ | |
|---|---|---|
Market Cap | $590.53M | — |
Sector | Health | — |
52-Week High | $16.14 | $746.16 |
52-Week Low | $5.48 | $553.88 |
Enterprise Value | $627.78M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQ, tracking the Nasdaq-100, trades at $711.79, down 1.9% over 24 hours amid a bearish technical signal. The ETF faces mixed sentiment with a 50/50 split in analyst ratings and news highlighting SpaceX's inclusion and competitive pressures from new funds like BlackRock's IQQ. Support sits near $700, with resistance at $717, while oscillators like the RSI remain neutral, suggesting indecision in the short term.
Outlook is cautious due to technical weakness and divided analyst views, though long-term exposure to tech giants offers growth potential. Risks include index concentration, fee competition, and macroeconomic shifts affecting rate-sensitive holdings, requiring careful monitoring of earnings trends from underlying companies.
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →